维亚生物科技控股集团（股票代码：01873）于2026年5月7日发布截至2026年4月30日止的股份变动月报表显示，本月内公司未有股份发行及回购活动，股本保持稳定。
根据公告，维亚生物科技控股集团法定/注册股本维持在4,000,000,000股，面值0.000025美元，对应注册股本总额100,000美元，与上期一致。报告期末公司已发行普通股2,129,882,353股，无库存股份。
截至报告期末，公司设有两项股份期权计划。首次公开发售前股份激励计划授出2,217,093股期权，无新增授出、行使、注销或失效变动；首次公开发售后购股权计划授出13,700,000股期权，同样无变动，若全部行使后于期末可发行或转让股份124,345,000股。
公司表示，已符合上市规则关于公众持股量的相关要求，并确认在本月度所有证券发行或转让事项均符合相关法律法规和香港联交所上市规则要求。公告由执行董事毛晨签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.